CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaetano, C.
Right arrow Articles by Thiele, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaetano, C.
Right arrow Articles by Thiele, C. J.

Cell Growth & Differentiation, Vol 2, Issue 10 487-493, Copyright © 1991 by American Association of Cancer Research


ARTICLES

Retinoic acid negatively regulates p34cdc2 expression during human neuroblastoma differentiation

C Gaetano, K Matsumoto and CJ Thiele
Molecular Genetics Section, National Cancer Institute, Bethesda, Maryland 20892.

p34cdc2 is a protein kinase that has an important role in controlling cell cycle progression and may regulate tumor suppressor gene activity. In this work, we show that the arrest of cell growth and induction of differentiation in a tumorigenic neuroblastoma cell line by retinoic acid (RA) is associated with a 75-fold decrease in the level of p34cdc2 protein. The RA induced decrease in p34cdc2 levels does not simply reflect the arrest of cell growth, because p34cdc2 levels are not reduced when neuroblastoma cells are growth arrested by nutrient deprivation. Furthermore, dephosphorylation of the tumor suppressor gene product RB, a substrate for the p34cdc2 kinase activity, is observed only when p34cdc2 levels are decreased in RA treated cells. These studies link regulation of cdc2 level, RB phosphorylation state, and induction of differentiation by RA and suggest that alterations in the cdc2 gene or in genes controlling its regulation contribute to tumorigenesis.


This article has been cited by other articles:


Home page
J Biol ChemHome page
N. D. Fernandes, Y. Sun, and B. D. Price
Activation of the Kinase Activity of ATM by Retinoic Acid Is Required for CREB-dependent Differentiation of Neuroblastoma Cells
J. Biol. Chem., June 1, 2007; 282(22): 16577 - 16584.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Gaetano, T. Matsuo, and C. J. Thiele
Identification and Characterization of a Retinoic Acid-regulated Human Homologue of the unc-33-like Phosphoprotein Gene (hUlip) from Neuroblastoma Cells
J. Biol. Chem., May 2, 1997; 272(18): 12195 - 12201.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
E. Lucarelli, D. R. Kaplan, and C. J. Thiele
Selective Regulation of TrkA and TrkB Receptors by Retinoic Acid and Interferon-{gamma} in Human Neuroblastoma Cell Lines
J. Biol. Chem., October 20, 1995; 270(42): 24725 - 24731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1991 by the American Association of Cancer Research.